ALNY
Alnylam Pharmaceuticals Inc
219.70$
-5.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -0.2% | -0.1% | +4.8% | +4.9% | +0.8% | -0.6% | +8.4% | +6.3% | +2.4% | +3.3% | +8.4% | |
| – | -0.1% | +0.2% | +6.2% | +5.8% | -1.8% | -0.8% | +11.5% | +8.5% | +2.5% | +4.2% | +9.5% | |
| – | -21.3% | -16.1% | +42.0% | +13.6% | -12.1% | +5.5% | +9.2% | +33.8% | +11.2% | +3.2% | -0.1% | |
| – | +1.4% | -2.8% | +10.7% | +5.9% | -3.1% | -2.3% | +8.6% | -4.7% | +6.7% | +3.5% | +9.9% | |
| – | +0.7% | -2.0% | -3.7% | +14.3% | +14.5% | +3.1% | +35.7% | +70.1% | -19.4% | +13.7% | +3.3% | |
| – | -6.9% | +5.4% | -10.6% | -9.5% | +3.3% | -16.5% | +9.3% | +5.2% | +9.7% | +1.6% | +15.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1.1% | -0.2% | -0.8% | +4.0% | +0.0% | -1.8% | +5.3% | +7.0% | -9.5% | -2.9% | +3.7% | |
| – | +1.9% | -2.7% | +12.1% | +15.7% | -2.8% | -9.3% | +20.9% | +19.6% | -5.7% | -8.0% | +12.1% | |
| – | 0.0% | +0.4% | 0.0% | +1.2% | -0.6% | +9.8% | +0.2% | -2.9% | +1.7% | +0.3% | +0.6% | |
| – | -24.8% | +40.8% | -5.3% | -4.3% | +24.9% | +10.2% | +5.1% | +14.8% | -1.6% | +9.4% | -14.7% | |
| – | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | +1.3% | -3.1% | +0.2% | +0.2% | |
| – | – | – | – | – | +107.4% | +72.1% | +117.1% | -6.7% | +237.4% | +36.3% | +25.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -4.4% | +0.4% | +0.5% | +1.5% | +0.0% | +0.8% | +0.0% | +5.9% | -0.8% | +1.4% | +0.0% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.